CHENG, Yun-Xing,ZHAO, Guiling,ROMERO, F. Anthony,GIBBONS, Paul,CHENG, Limin,YUEN, Po-Wai,ZAK, Mark,LI, Wei
申请号：
CR20190310
公开号：
CR20190310A
申请日:
2017.12.22
申请国别(地区):
CR
年份:
2019
代理人:
摘要：
This document describes the formulation compound (IA) or pharmaceutically acceptable salts, and methods for use as sodium sulfite inhibitors, including formulation compound (IA) or acceptable salt salt salt, and methods for using sodium sulfite.En el presente documento se describen compuestos de fórmula (IA) o una sal farmacéuticamente aceptable de los mismos y métodos de uso como inhibidores de Janus cinasa.Compounds of Formula (IA), or a pharmaceutically acceptable salt thereof, and methods of use as Janus kinase inhibitors are described herein.
